Wir verwenden standardmäßig essenzielle Cookies (Anmeldung, deine gespeicherten Ziele/Stacks). Mit deiner Erlaubnis aktivieren wir außerdem datenschutzfreundliche Analytik (Vercel Web Analytics, anonyme Ladezeit-Metriken) und Fehler-Replay-Diagnostik (Sentry — DOM-Snapshots nur, wenn ein Fehler auftritt), damit wir Bugs schneller beheben können. Mehr über Cookies erfahren

Aspirin (niedrig dosiert) – Forschungsarchiv – Seite 30 von 60 | SupStack

Aspirin (niedrig dosiert) – Forschungsarchiv

Studien 2401–2450 von 3915, neueste zuerst

Die 1000 neuesten Studien – mit Evidenz-Zusammenfassung, Filtern und Suche – stehen auf der Hauptseite. Dieses Archiv listet die übrigen, 50 pro Seite. Zurück zur Hauptseite

2401RCT2003

Pleym H, Stenseth R, Wahba A, Bjella L, Karevold A, Dale O · Anesth Analg (2003)

Für dieses Zitat ist keine Zusammenfassung hinterlegt — öffne die Arbeit, um das Abstract zu lesen.

Aspirin (niedrig dosiert) – Forschungsarchiv

Single-dose tranexamic acid reduces postoperative bleeding after coronary surgery in patients treated with aspirin until surgery.

Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.

A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis.

Design, progress and challenges of a double-blind trial of warfarin versus aspirin for symptomatic intracranial arterial stenosis.

Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.

Naproxen as an alternative to aspirin for the treatment of arthritis of rheumatic fever: a randomized trial.

Effects of PEG-hirudin in clotting parameters and platelet function and its interaction with aspirin in healthy volunteers.

Enhanced interleukin-1beta in hypercholesterolemia: effects of simvastatin and low-dose aspirin.

Effects of cyclooxygenases inhibitors on vasoactive prostanoids and thrombin generation at the site of microvascular injury in healthy men.

Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa.

Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.

Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial.

Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.

Influence of aspirin on inflammatory markers in patients after acute myocardial infarction.

Effects of aspirin (325 mg/day) on serum high-sensitivity C-reactive protein, cytokines, and adhesion molecules in healthy volunteers.

Anticoagulant and aspirin prophylaxis for preventing thromboembolism after major gynaecological surgery.

Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.

Administration time-dependent effects of aspirin on blood pressure in untreated hypertensive patients.

[Acetylsalicylic acid for prevention of colorectal adenomas. The APP Study].

A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin.

Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation.

Antagonism of the acute hemodynamic effects of captopril in decompensated congestive heart failure by aspirin administration.

The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.

Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses.

Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.

Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation.

Effect of additional temporary glycoprotein IIb/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial).

Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study.

Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials.

Department of Veterans Affairs Cooperative Studies Program Clinical Trial comparing combined warfarin and aspirin with aspirin alone in survivors of acute myocardial infarction: primary results of the CHAMP study.

Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial.

[Acetylsalicylic acid in primary prevention of cardiovascular events; literature study].

Effects of long-term treatment with angiotensin-converting-enzyme inhibitors in the presence or absence of aspirin: a systematic review.

Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.

Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers.

Prokinetic effect of Alka-Seltzer in healthy subjects.

A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation.

The effect of aspirin on the periodontal parameter bleeding on probing.

Heparin and coumadin versus acetylsalicylic acid for prevention of restenosis after coronary angioplasty.

Do changes in visceral sensory function determine the development of dyspepsia during treatment with aspirin?

Aspirin alone antiplatelet regimen after intracoronary placement of the Carbostent: the ANTARES study.

Aspirin prophylaxis in patients at low risk for cardiovascular disease: a systematic review of all-cause mortality.

Enoxaparin in acute coronary syndromes: evidence for superiority over placebo or untreated control.

Aspirin in diabetic retinopathy. A systematic review.

Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.

[The effect of aspirin on rheological properties of erythrocytes in essential hypertension].

Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment.

Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study.

Safety of rofecoxib in subjects with a history of adverse cutaneous reactions to aspirin and/or non-steroidal anti-inflammatory drugs.

Seeking the optimal aspirin dose in acute coronary syndromes.